Comparing West Pharmaceutical Services (NYSE:WST) and Golf Rounds.com (OTCMKTS:FZMD)

Golf Rounds.com (OTCMKTS:FZMD) and West Pharmaceutical Services (NYSE:WST) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, profitability and valuation.

Profitability

This table compares Golf Rounds.com and West Pharmaceutical Services’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Golf Rounds.com	N/A	N/A	N/A
West Pharmaceutical Services	16.48%	18.43%	13.67%

Institutional & Insider Ownership

93.9% of West Pharmaceutical Services shares are owned by institutional investors. 92.3% of Golf Rounds.com shares are owned by insiders. Comparatively, 0.6% of West Pharmaceutical Services shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Golf Rounds.com and West Pharmaceutical Services”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Golf Rounds.com	$10.73 million	N/A	$510,000.00	N/A	N/A
West Pharmaceutical Services	$2.89 billion	6.77	$492.70 million	$6.68	40.77

West Pharmaceutical Services has higher revenue and earnings than Golf Rounds.com.

Analyst Recommendations

This is a summary of recent ratings and price targets for Golf Rounds.com and West Pharmaceutical Services, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Golf Rounds.com	0	0	0	0	0.00
West Pharmaceutical Services	0	4	7	2	2.85

West Pharmaceutical Services has a consensus price target of $321.89, indicating a potential upside of 18.19%. Given West Pharmaceutical Services’ stronger consensus rating and higher possible upside, analysts plainly believe West Pharmaceutical Services is more favorable than Golf Rounds.com.

Volatility & Risk

Golf Rounds.com has a beta of -0.86, meaning that its share price is 186% less volatile than the S&P 500. Comparatively, West Pharmaceutical Services has a beta of 1.07, meaning that its share price is 7% more volatile than the S&P 500.

Summary

West Pharmaceutical Services beats Golf Rounds.com on 11 of the 12 factors compared between the two stocks.

About Golf Rounds.com

Fuse Medical, Inc. manufactures and distributes medical devices in the United States. The company offers orthopedic implants, including internal and external fixation products for foot and ankle; upper and lower extremity plating and total joint reconstruction implants; soft tissue fixation and augmentation for sports medicine procedures; and full spinal implants for trauma, degenerative disc disease, and deformity indications. It also provides osteo-biologics and regenerative products, which include human allografts, tendons, synthetic skin and bone substitute materials, and regenerative tissues. The company serves hospitals, medical facilities, and sub-distributors. Fuse Medical, Inc. is based in Richardson, Texas.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.